Skip to main content
High RiskFDAfda-F-0724-2016OTHER

Maesri Brand Shrimp Powder, 6.oz

Category
Units Affected
945
Recall Date
October 20, 2015
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0724-2016.

The New York Department of Agriculture and Markets notified Eastland Food Corp. that they analyzed a sample of the shrimp powder and determined that the product contained FD&C Yellow #6, but the label failed to declare its presence. Yellow #6 can cause an allergic reaction for a small population of individuals.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0724-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Eastland Food Corporation or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0724-2016.

Eastland Food Corporation

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Eastland Food Corporation Recall FAQ

Eastland Food Corporation is the subject of a seafood safety report: Maesri Brand Shrimp Powder, 6.oz. The notice was published on October 20, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 945 units are potentially affected.